NASDAQ · MGRX
Healthcare · Medical - Healthcare Information Services
$0.53
Up+$0.00 (+0.23%)
Updated Aug 15, 2026, 4:02 AM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 21 trading sessions · Daily adjusted prices
MGRX closed at $0.53 after 21 trading sessions, up 29.77% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $0.5844 | $0.5984 | $0.4717 | $0.5344 | 21.11M |
| Aug 13, 2026 | $0.52 | $0.5899 | $0.52 | $0.5332 | 27.62M |
| Aug 12, 2026 | $0.5186 | $0.5532 | $0.4879 | $0.533 | 967.23K |
| Aug 11, 2026 | $0.5662 | $0.6024 | $0.5351 | $0.546 | 1.37M |
| Aug 10, 2026 | $0.465 | $0.61 | $0.4562 | $0.5945 | 4.99M |
| Aug 7, 2026 | $0.4797 | $0.4939 | $0.4503 | $0.4921 | 4.27M |
| Aug 6, 2026 | $0.592 | $0.63 | $0.4868 | $0.527 | 52.48M |
| Aug 5, 2026 | $0.414 | $0.4676 | $0.40 | $0.4255 | 62.97M |
| Aug 4, 2026 | $0.4701 | $0.5099 | $0.422 | $0.458 | 3.59M |
| Aug 3, 2026 | $0.432 | $0.555 | $0.4155 | $0.536 | 15.12M |
| Jul 31, 2026 | $0.641 | $1.25 | $0.5166 | $0.5571 | 512.12M |
| Jul 30, 2026 | $0.42 | $0.42 | $0.261 | $0.2936 | 80.54M |
| Jul 29, 2026 | $0.56 | $0.56 | $0.52 | $0.5527 | 274.26K |
| Jul 28, 2026 | $0.5421 | $0.597 | $0.5421 | $0.556 | 650.39K |
| Jul 27, 2026 | $0.51 | $0.5729 | $0.51 | $0.543 | 472.04K |
| Jul 24, 2026 | $0.55 | $0.569 | $0.51 | $0.5207 | 467K |
| Jul 23, 2026 | $0.53 | $0.57 | $0.5253 | $0.5574 | 491.46K |
| Jul 22, 2026 | $0.4793 | $0.5679 | $0.4709 | $0.511 | 1.04M |
| Jul 21, 2026 | $0.4303 | $0.5151 | $0.417 | $0.471 | 1.41M |
| Jul 20, 2026 | $0.424 | $0.4468 | $0.4101 | $0.4211 | 224.91K |
| Jul 17, 2026 | $0.39 | $0.438 | $0.38 | $0.4118 | 328.85K |
The latest Smart Investors Daily articles mentioning MGRX.
MGRX research
Company profile and research snapshot.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Benzinga · Aug 6, 2026
MoU with New Mining Co. ("New Mining"), a Miami-headquartered provider of high-density digital infrastructure and computing hosting services, to evaluate the technical and structural feasibility of deploying
Benzinga · Aug 6, 2026
Mangoceuticals Shares surged 49.24% after hours as Nuclea Energy advanced nuclear reactor plans boosted merger-related optimism.
Benzinga · Aug 5, 2026
Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company") today announced that its merger partner’s wholly owned subsidiary, Nuclea Energy USA Inc. ("Nuclea USA"), has signed a
Benzinga · Mar 6, 2026
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning MGRX.
